Active filters
Displaying 15 of 15 results
Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
1992
1 resource
Available online
DailyMed.
Web resource
Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, [2005]-
2005
1 resource
Available online
Guidance for industry : indexing structured product labeling.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2008]
2008
1 resource
Available online
Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, [2008]
2008
1 resource
Available online
Guidance for industry and review staff : labeling for human prescription drug and biological products : determining established pharmacologic class for use in the highlights of prescribing information.
Web resource
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Rockville, MD : Center for Biologics Evaluation and Research, [2009]
2009
1 resource
Available online
Guidance for industry : public availability of labeling changes in "changes being effected" supplements.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2006]
2006
1 resource
Available online
Guidance for industry : content and format for geriatric labeling.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2001]
2001
1 resource
Available online
Guidance for industry : dosage and administration section of labeling for human prescription drug and biological products, content and format.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2007]
2007
1 resource
Available online
Guidance for industry : hypertension indication, drug labeling for cardiovascular outcome claims.
Web resource
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2008]
2008
1 resource
Available online
Guidance for industry : labeling for human prescription drug and biological products, implementing the new content and format requirements.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2006]
2006
1 resource
Available online
Guidance for industry : warnings and precautions, contraindications, and boxed warning sections of labeling for human prescription drug and biological products, content and format.
Web resource
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2006]
2006
1 resource
Available online
Protecting seniors from medication labeling mistakes : hearing before the Special Committee on Aging, United States Senate, One Hundred Thirteenth Congress, first session, Washington, DC, December 11, 2013.
Web resource
Washington : U.S. Government Publishing Office, 2017.
2017
1 resource
Available online
Informing patients about drugs--analysis of alternative designs for flurazepam leaflets / Sandra H. Berry ... [et al.] ; prepared for the Food and Drug Administration.
Book/text
Santa Monica, Ca. : Rand, 1981.
1981
1 item
Call number | AS36 .R3 R-2799-FDA |
Item location | Off-site |
Informing patients about drugs--analysis of alternative designs for erythromycin leaflets / John D. Winkler ... [et al.] ; prepared for the Food and Drug Administration.
Book/text
Santa Monica, Ca. : Rand, 1981.
1981
1 item
Call number | AS36 .R3 R-2798-FDA |
Item location | Off-site |
Informing patients about drugs--analysis of alternative designs for estrogen leaflets / David E. Kanouse ... [et al.] ; prepared for the Food and Drug Administration.
Book/text
Santa Monica, CA : Rand Corp., 1981.
1981
1 item
Call number | AS36 .R3 R-2800-FDA |
Item location | Off-site |